resistant to acamprosate and naltrexone. Patients reported that during relapses they engaged in binge drinking associated with aggression with amnesia, mood and sleep problems followed by withdrawal symptoms upon arresting alcohol intake. Behavioral treatment in outpatient individualized sessions, group sessions, and inpatient treatment in a general hospital as well as a specialized addiction hospital all yielded only temporary success. See Table 1 for Table demographics, anthropometric and laboratory measures.Table 1Demographics, anthropometric and laboratory measures for alcohol addicted participants. Alcohol addicted (n = 11)Age (years)48.12 (8.54)Gender♂ 8 ♀ 3Body weight (kg)73.30 (10.55)Height (cm)175.21 (12.38)BMI23.9 (2.05)NRS Desire alcohol18.32 (1.87)Audit236.21 (5.89)Cholesterol (mmol/L)4.77 (0.85)Triglycerides (mmol/L)1.65 (1.19)HDL (mmol/L)1.47 (0.43)GGT (U/L)91.79 (72.63)ALT (U/L)43.07 (30.39)AST (U/L)39.14 (34.28)Glucose (mmol/L)5.04 (0.54)1Numeric rating scale (how much do you desire for alcohol?).2Audit (Alcohol Use Disorders Identification test) scores of 20 or above clearly warrant further diagnostic evaluation for alcohol dependence.
